Is Meclozine + Pyridoxine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Meclozine + Pyridoxine, including VOMINORE TAB (50,25 mg,mg, Tablet, SAR 10.00); Vominore (25,50 mg,mg, Tablet, SAR 377.65).

Active substances

Meclozine + Pyridoxine

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
VOMINORE TAB	50,25 mg,mg	Tablet · Oral use	20 Blister	SAR 10.00	Generic · OTC	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
Vominore	25,50 mg,mg	Tablet · Oral use	1000 Blister	SAR 377.65	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid

Indications — CHI Daman Drug Formulary

NAUSEA AND VOMITING IN PREGNANCY; RENAL TRANSPLANT; VERTIGO - MOTION SICKNESS

Components

Pyridoxine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.